Fri.Jul 04, 2025

article thumbnail

Next drug patent cliff to challenge Big Pharma strategy

European Pharmaceutical Review

Multiple blockbuster drugs set to lose exclusivity, producing one of the pharmaceutical industry’s most financially significant patent cliffs in over a decade, according to GlobalData. Oncology is one of the key therapy areas set to be affected by pricing pressures as drug patents expire. Pharma companies will need to “rethink revenue strategies, pipeline investments, and lifecycle management to safeguard long-term growth”, as a greater number of biosimilars and generic medicines gain market ent

article thumbnail

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma welcomes EU push to restore life sciences sector

pharmaphorum

European pharma trade group EFPIA has said that a strategy launched by the EU to bolster the region's standing in life sciences is a "step forward.

71
article thumbnail

Pharmacy First proves popular with public but supply issues cause concern

The Pharmacist

New research has found high levels of public satisfaction with Pharmacy First in England, while also revealing significant problems with medication shortages. Healthwatch England sought the views of 7,029 adults, of which 3,104 (44%) had visited their pharmacy for help with one of the seven common conditions covered under the Pharmacy First initiative.

52
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

FDA approves Hikma’s Tyzavan for multiple infections

Pharmaceutical Business Review

Tyzavan is indicated for the treatment of several serious infections in adults and children one month and above, including septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. This new vancomycin is the only FDA-approved product that can be used directly from room temperature storage, eliminating the need for compounding, thawing, activation, or dilution.

article thumbnail

Commercial Analytics in Pharma and Life Sciences 

Viseven

Research and development costs keep climbing, competition is fiercer than ever, and market entry barriers are at an all-time low. So, what do you do? Right – you make smarter marketing decisions. Advances in technology give us deeper insights into pharma industry trends and, more importantly, the reasons behind them. Understanding the “why” helps anticipate customer behaviors and identify opportunities that ensure the largest returns.

More Trending

article thumbnail

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Advanced Solutions for Sustained Delivery of Ocular Therapies

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Dosage 64
article thumbnail

Elevated Remnant Cholesterol, Lp-PLA2 Linked to Heightened Risk of Composite Adverse Events

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in the US

Express Pharma

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent are bioequivalent to Atrovent Nasal Spray, 0.03 per cent and 0.06 per cent, of Boehringer Ingelheim Pharmaceuticals. Ipratropium Bromide Nasal Solution (Nasal Spray) 0.03 per cent is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennia

82
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Interview: BEM awardee Amish Patel reflects on royal recognition

The Pharmacist

The Pharmacist speaks to recent Medallist of the Order of the British Empire (BEM) awardee and chair of Kent local pharmaceutical committee (LPC) Amish Patel on the changes he has seen at his Kent pharmacy and how his and role has evolved. When community pharmacist Amish Patel BEM went abroad to celebrate his 40th birthday, he […] The post Interview: BEM awardee Amish Patel reflects on royal recognition appeared first on The Pharmacist.

45
article thumbnail

The quiet crisis: why medicines operations matter more than ever in the ICB era

Pharmafile

In the second of the Gateway to Local Access series, Vision4Health caught up with Dr Graham Duce, ICB GP Prescribing and Clinical Lead, to discuss his views on the role of medicines operations teams in the new ICB structures. The post The quiet crisis: why medicines operations matter more than ever in the ICB era appeared first on Pharmafile.

59
article thumbnail

Updated NHS App to help patients manage prescriptions

The Pharmacist

A revamped NHS App will help patients manage and remember their prescriptions and guide them on their specific drug reaction and interaction risks, according to the government’s 10 year plan for the NHS. The ‘Fit for the future: 10 year health plan for England,’ released yesterday, will include a ‘My Medicines’ tool on the App […] The post Updated NHS App to help patients manage prescriptions appeared first on The Pharmacist.

66
article thumbnail

UK pharma has concerns about the new NHS 10-year plan

pharmaphorum

The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatment

Pharmafile

Johnson & Johnson has submitted an application to the European Medicines Agency for an indication extension of Akeega (niraparib and abiraterone acetate dual action tablet), aiming to treat adult patients with metastatic hormone-sensitive prostate cancer who carry homologous recombination repair (HRR) gene alterations. The submission builds on positive results from the company’s phase 3 AMPLITUDE […] The post Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatm

66
article thumbnail

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

AZ claims EU okay for Imfinzi in bladder cancer

pharmaphorum

AstraZeneca passes another milestone in its journey to rebuild Imfinzi's presence in bladder cancer, a key growth driver for the drug

52
article thumbnail

Interview: OBE awardee Amish Patel reflects on royal recognition

The Pharmacist

The Pharmacist speaks to recent Order of the British Empire (OBE) awardee and chair of Kent local pharmaceutical committee (LPC) Amish Patel on the changes he has seen at his Kent pharmacy and how his and role has evolved. When community pharmacist Amish Patel OBE went abroad to celebrate his 40th birthday, he never imagined […] The post Interview: OBE awardee Amish Patel reflects on royal recognition appeared first on The Pharmacist.

40
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Brii Biosciences and Joincare sign licence agreement for BRII-693

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Shingles and RSV Vaccines Show Promise Against Dementia

Pharmacy Times

Recent research reveals that RSV and shingles vaccines significantly lower dementia risk, highlighting the potential benefits of AS01 adjuvants in vaccination.

article thumbnail

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Researchers identify new protein target to control chronic inflammation

World Pharma News

Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or cancer or autoimmune disorders, weigh heavily on human health - and experts anticipate their incidence is on the rise. A new study by investigators from Mass General Brigham identified a protein called WSTF that could be targeted to block chronic inflammation.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Modella AI and AstraZeneca link for cancer clinical development

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Hospitalized Adults With Community-Acquired Pneumonia Suffer Significant Morbidity Postdischarge

Pharmacy Times

Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability to perform activities and experiencing poor quality of life.

article thumbnail

Five lessons from biopharma companies’ data transformation journeys

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

FDA grants accelerated approval for advanced non-small cell lung cancer treatment

Pharmafile

The US Food and Drug Administration (FDA) has granted accelerated approval to Dizal Therapeutic’s Zegfrovy (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations. This covers patients whose disease has progressed following platinum-based chemotherapy.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A look back to ASCO 2025: Industry comments from iOnctura and Asgard Therapeutics

pharmaphorum

Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard Therapeutics – share their views on the broader cancer care landscape and ponder what’s hyped, what’s not being duly appreciated, and what might be coming next.

52
article thumbnail

Biocon Biologics gains EU approval for bone health therapies

Pharmafile

Biocon Biologics has announced that the European Commission has granted marketing authorisation for its denosumab biosimilars, Vevzuo and Evfraxy, marking a significant step in expanding patient access to critical bone health treatments across Europe. Vevzuo is approved for the prevention of skeletal complications in adults with advanced cancers involving bone, as well as for treating […] The post Biocon Biologics gains EU approval for bone health therapies appeared first on Pharmafile.

article thumbnail

Endometriosis market to grow to $2.5 bn across 7MM in 2034

Express Pharma

The endometriosis market across the seven major markets (7MM*) is forecast to increase at a compound annual growth rate (CAGR) of 10.3 per cent from $938.0 million in 2024 to $2.5 billion in 2034, forecasts GlobalData. GlobalData’s latest report, “Endometriosis: Seven Market Drug Forecast and Market Analysis,” reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction of several key pipeline therapies, including Kissei Pharmaceutical’s Yselty (linzago

article thumbnail

Closed & Collaborative H1 2025: Mergers, acquisitions, collaborations, and partnerships in life sciences

pharmaphorum

Closed & Collaborative H1 2025: Mergers, acquisitions, collaborations, and partnerships in life sciences Nicole.

64
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.